<http://webisa.webdatacommons.org/prov/435405624>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/31955883> .
<http://webisa.webdatacommons.org/31955883>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/31955883>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<bio-medicine.org> .
<http://webisa.webdatacommons.org/31955883>	<http://www.w3.org/ns/prov#value>	"Secures FDA Approval of Rasuvo (methotrexate) injection for Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis and Psoriasisients with psoriasis or rheumatoid arthritis with severe recalcitrant disabling disease which is not adequately responsive to other forms of therapy." .